Mosaic ImmunoEngineering Inc (CPMV)
0.40
+0.01
(+2.56%)
USD |
OTCM |
May 17, 16:00
Mosaic ImmunoEngineering 1 Year Total Returns (Daily): -60.00% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -60.00% |
May 16, 2024 | -51.31% |
May 15, 2024 | -50.06% |
May 14, 2024 | -50.06% |
May 13, 2024 | -50.06% |
May 10, 2024 | -52.67% |
May 09, 2024 | -51.31% |
May 08, 2024 | -60.00% |
May 07, 2024 | -62.00% |
May 06, 2024 | -40.00% |
May 03, 2024 | -40.00% |
May 02, 2024 | -40.00% |
May 01, 2024 | -40.00% |
April 30, 2024 | -41.12% |
April 29, 2024 | -68.69% |
April 26, 2024 | -70.04% |
April 25, 2024 | -70.04% |
April 24, 2024 | -63.21% |
April 23, 2024 | -68.70% |
April 22, 2024 | -68.70% |
April 19, 2024 | -55.34% |
April 18, 2024 | -63.47% |
April 17, 2024 | -31.26% |
April 16, 2024 | -31.26% |
April 15, 2024 | -31.26% |
Date | Value |
---|---|
April 12, 2024 | -31.26% |
April 11, 2024 | -60.88% |
April 10, 2024 | -56.25% |
April 09, 2024 | -58.82% |
April 08, 2024 | -58.82% |
April 05, 2024 | -58.82% |
April 04, 2024 | -58.82% |
April 03, 2024 | -56.25% |
April 02, 2024 | -58.82% |
April 01, 2024 | -61.96% |
March 28, 2024 | -63.26% |
March 27, 2024 | -60.39% |
March 26, 2024 | -60.39% |
March 25, 2024 | -37.51% |
March 22, 2024 | -45.01% |
March 21, 2024 | -37.68% |
March 20, 2024 | -37.76% |
March 19, 2024 | -37.69% |
March 18, 2024 | -37.69% |
March 15, 2024 | -37.69% |
March 14, 2024 | -37.69% |
March 13, 2024 | -37.69% |
March 12, 2024 | -63.23% |
March 11, 2024 | -63.23% |
March 08, 2024 | -44.53% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.43%
Minimum
Dec 23 2021
555.0%
Maximum
Mar 11 2021
5.18%
Average
-37.50%
Median
Aug 08 2019
1 Year Total Returns (Daily) Benchmarks
Oncotelic Therapeutics Inc | 5.56% |
NovaBay Pharmaceuticals Inc | -83.53% |
Palatin Technologies Inc | -18.03% |
iBio Inc | -89.71% |
Theriva Biologics Inc | -47.04% |